News Release VacciXcell

News


 

ISCT 2020 Paris Virtual Event Appreciation

 

Jun 03, 2020

 

 

Esco Aster was recently live at the ISCT 2020 Paris Virtual event from May 28 to May 29. We would like to thank all for visiting our virtual booth and viewing our poster on "Large Scale 3D Bioreactor Technology: Linear Scale Up of Mesenchymal Stromal Cell Expansion With TideXcell™ System". This was our first participation in a virtual event and we appreciate your enquiries about our innovative and patented technology in this leading event dedicated to promoting translation of cell and gene therapies.

Access to our virtual booth and poster ends on May 26, 2021 – Attendees can still view our poster at the ISCT Poster Hall, under Process Development & Facility Operations and visit our virtual booth at the Exhibit Hall.

Esco Aster Poster on ”Large Scale 3D Bioreactor Technology: Linear Scale Up of Mesenchymal Stromal Cell Expansion With TideXcell™ System

Esco Aster Poster on “Large Scale 3D Bioreactor Technology: Linear Scale Up of Mesenchymal Stromal Cell Expansion With TideXcell™ System”

 

About Esco Aster

Esco Aster is a contract development and manufacturing organisation (CDMO) focusing on offering vaccine-, bio-, cell- and gene-therapy development manufacturing services using primarily its proprietary adherent Tide Motion platform supplemented by single use suspension and fermentation, downstream bioprocessing, and custom bioengineering equipment for client specific therapeutics.

Within the in vitro/in vivo Dx space we focus on developing mAb-based antigens, single domain antibodies for radioimaging, RT-PCR reagents, RCL diagnostics. We work with collaborators to provide turnkey mobile Dx labs Aster Xpress™.

Within the chem- biopolymer- cosmetic, personal care, cosmeceutical- segments, we excel in converting batch processes into continuous flow chemistry, closed aseptic processing within isolators and variety of skin safety/efficacy testing services.

For the COVID-19 pandemic, we are working on an end to end trace, test, and treat platform from swab booths, to mobile labs, turnkey modular screening, and treatment centres with isolation rooms as well as working on Dx, therapeutics and vaccines.